logodt

S&T BioMed Co., Ltd.

inquiry_icon Inquiry

About Company

S&T BioMed Co., Ltd. is a biotechnology company focused on in vitro diagnostics (IVD) and biomarker-based detection technologies, dedicated to early cancer screening and disease monitoring. The company possesses strong in-house R&D capabilities, covering biomarker discovery, assay development, clinical validation, and product commercialization, enabling the development of clinically valuable and market-competitive diagnostic solutions. S&T BioMed’s current focus is saliva-based oral cancer detection, utilizing a non-invasive sampling method that is convenient, safe, and highly acceptable to users. These solutions are suitable for hospitals, clinics, community screening programs, and point-of-care or out-of-hospital settings. The company has established a comprehensive product portfolio, including rapid screening tests and quantitative assays, providing integrated solutions for first-line screening and follow-up monitoring. In terms of commercialization, S&T BioMed adopts flexible business models, including direct product sales, distributor partnerships, and OEM/ODM collaborations. This strategy enables rapid market expansion and supports local partners in introducing products efficiently. S&T BioMed has successfully obtained regulatory approvals and commercialization rights in multiple regions, including Europe, Thailand, Vietnam, Australia, Singapore, Hong Kong, the Philippines, and Malaysia. These international approvals demonstrate the company’s strong regulatory capabilities and global market competitiveness. Moving forward, S&T BioMed will continue expanding its non-invasive diagnostic platform and developing additional cancer and disease detection solutions, with the vision of becoming a global leader in innovative early detection technologies.

Product Name

Through a non-invasive biomarker detection service platform, simple, rapid, and accurate cancer testing can be performed, effectively improving disease management. Product Categories: In Vitro Diagnostic (IVD) Reagents – Immunoassay Test Kits Oral Cancer Detection Kit (ELISA Kit) Oral Cancer Rapid Strip Test (Rapid Strip Test, RST) Laboratory Testing – Targeted Quantitative Mass Spectrometry (Multi-Biomarker Panel) Oral Cancer Saliva Detection Kit Colorectal Cancer Blood Exosome Detection Kit Pancreatic Cancer / Biliary Tract Cancer Blood Exosome Detection Kit Gastric Cancer Blood Exosome Detection Kit

Product Info

(1)EarlyFound® MMP-1 ELISA kit Quantitative saliva test for high-throughput labs. Validated in 3,586 samples with 94.3% sensitivity and 98.6% specificity. Approved in EU, Singapore, Australia, Hong Kong, Thailand, Vietnam, and Philippines; Malaysia and Indonesia in progress. (2)EarlyFound® MMP-1 Rapid Strip Test Saliva-based oral cancer screening test for self-use and point-of-care settings. Validated in 1,029 specimens with 96% sensitivity, 100% specificity, and 98% accuracy. Approved under CE (IVDD) and Singapore HSA, with registrations in progress across Asia-Pacific markets.

Product Image

Company Image

Get in touch directly with us.

+886-2-7756-1768

6F., No. 26, Sec. 3, Nanjing E. Rd., Zhongshan Dist., Taipei City 104103 , Taiwan